1. 首頁 > 生活雜燴 > 健康養生 > >

of|為什么益生菌能減肥？科學家：這3點是關鍵( 二 )



含有益生元的勻初態復合益生菌制劑比單一的益生菌制劑具有更強的活性和調節作用，“不節食、不運動、不反彈”，是減脂人真正的“快樂星球”，減肥勻初態，重返健康態！

參考資料：

[1] C.D. Davis, The Gut Microbiome and Its Role in Obesity, Nutr Today 51(4) (2016) 167-174.

[2] E. Le Chatelier, T. Nielsen, J. Qin, E. Prifti, F. Hildebrand, G. Falony, M. Almeida, M. Arumugam, J.M. Batto, S. Kennedy, P. Leonard, J. Li, K. Burgdorf, N. Grarup, T. Jorgensen, I. Brandslund, H.B. Nielsen, A.S. Juncker, M. Bertalan, F. Levenez, N. Pons, S. Rasmussen, S. Sunagawa, J. Tap, S. Tims, E.G. Zoetendal, S. Brunak, K. Clement, J. Dore, M. Kleerebezem, K. Kristiansen, P. Renault, T. Sicheritz-Ponten, W.M. de Vos, J.D. Zucker, J. Raes, T. Hansen, H.I.T.c. Meta, P. Bork, J. Wang, S.D. Ehrlich, O. Pedersen, Richness of human gut microbiome correlates with metabolic markers, Nature 500(7464) (2013) 541-6.

[4] C.M. Stark, A. Susi, J. Emerick, C.M. Nylund, Antibiotic and acid-suppression medications during early childhood are associated with obesity, Gut 68(1) (2019) 62-69.

[5] M. Wicinski, J. Gebalski, J. Golebiewski, B. Malinowski, Probiotics for the Treatment of Overweight and Obesity in Humans-A Review of Clinical Trials, Microorganisms 8(8) (2020).

[10] H. Koutnikova, B. Genser, M. Monteiro-Sepulveda, J.M. Faurie, S. Rizkalla, J. Schrezenmeir, K. Clement, Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials, BMJ Open 9(3) (2019) e017995.

[12] K.L. Osterberg, N.E. Boutagy, R.P. McMillan, J.R. Stevens, M.I. Frisard, J.W. Kavanaugh, B.M. Davy, K.P. Davy, M.W. Hulver, Probiotic supplementation attenuates increases in body mass and fat mass during high-fat diet in healthy young adults, Obesity (Silver Spring) 23(12) (2015) 2364-70.

[13] R. Jumpertz, D.S. Le, P.J. Turnbaugh, C. Trinidad, C. Bogardus, J.I. Gordon, J. Krakoff, Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans, Am J Clin Nutr 94(1) (2011) 58-65.

[14] P.J. Turnbaugh, R.E. Ley, M.A. Mahowald, V. Magrini, E.R. Mardis, J.I. Gordon, An obesity-associated gut microbiome with increased capacity for energy harvest, Nature 444(7122) (2006) 1027-31.

[15] G. den Besten, K. van Eunen, A.K. Groen, K. Venema, D.J. Reijngoud, B.M. Bakker, The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism, J Lipid Res 54(9) (2013) 2325-40.

[16] J. Soldavini, J.D. Kaunitz, Pathobiology and potential therapeutic value of intestinal short-chain fatty acids in gut inflammation and obesity, Dig Dis Sci 58(10) (2013) 2756-66.

[18] B. Jayashree, Y.S. Bibin, D. Prabhu, C.S. Shanthirani, K. Gokulakrishnan, B.S. Lakshmi, V. Mohan, M. Balasubramanyam, Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes, Mol Cell Biochem 388(1-2) (2014) 203-10.

[19] H.M. Roager, T.R. Licht, Microbial tryptophan catabolites in health and disease, Nat Commun 9(1) (2018) 3294.

[20] M. Zarrati, E. Salehi, K. Nourijelyani, V. Mofid, M.J. Zadeh, F. Najafi, Z. Ghaflati, K. Bidad, M. Chamari, M. Karimi, F. Shidfar, Effects of probiotic yogurt on fat distribution and gene expression of proinflammatory factors in peripheral blood mononuclear cells in overweight and obese people with or without weight-loss diet, J Am Coll Nutr 33(6) (2014) 417-25.